Home

Werkzeug Recorder Staubig aigner und fischer pharmazie 70 2015 1 8 mechanisch Folter prüfen

Frontiers | Drug Resistance and Novel Therapeutic Approaches in Invasive  Candidiasis | Cellular and Infection Microbiology
Frontiers | Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis | Cellular and Infection Microbiology

Targeted Immunotherapy for Autoimmune Disease
Targeted Immunotherapy for Autoimmune Disease

PDF) Recent Heterocyclic Compounds from (1 ,3‐Dioxo‐2,3‐dihydro‐1H‐inden‐2‐ylidene)propanedinitrile
PDF) Recent Heterocyclic Compounds from (1 ,3‐Dioxo‐2,3‐dihydro‐1H‐inden‐2‐ylidene)propanedinitrile

CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy:  Challenges and Opportunities for Nonviral Delivery | Chemical Reviews
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery | Chemical Reviews

Bioengineering | Free Full-Text | Membrane Technological Pathways and  Inherent Structure of Bacterial Cellulose Composites for Drug Delivery |  HTML
Bioengineering | Free Full-Text | Membrane Technological Pathways and Inherent Structure of Bacterial Cellulose Composites for Drug Delivery | HTML

Ki-67 Antibody (14-5698-82)
Ki-67 Antibody (14-5698-82)

Ki-67 Antibody (14-5698-82)
Ki-67 Antibody (14-5698-82)

Membrane Interactions of α-Synuclein Revealed by Multiscale Molecular  Dynamics Simulations, Markov State Models, and NMR | The Journal of  Physical Chemistry B
Membrane Interactions of α-Synuclein Revealed by Multiscale Molecular Dynamics Simulations, Markov State Models, and NMR | The Journal of Physical Chemistry B

IJMS | Free Full-Text | SSAO/VAP-1 in Cerebrovascular Disorders: A  Potential Therapeutic Target for Stroke and Alzheimer's Disease | HTML
IJMS | Free Full-Text | SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease | HTML

Ki-67 Antibody (14-5698-82)
Ki-67 Antibody (14-5698-82)

Scaffold mediated delivery of dual miRNAs to transdifferentiate cardiac  fibroblasts - ScienceDirect
Scaffold mediated delivery of dual miRNAs to transdifferentiate cardiac fibroblasts - ScienceDirect

Modularized Gold Nanocarriers for TAT‐Mediated Delivery of siRNA - Huang -  2017 - Small - Wiley Online Library
Modularized Gold Nanocarriers for TAT‐Mediated Delivery of siRNA - Huang - 2017 - Small - Wiley Online Library

Organotypic and Microphysiological Human Tissue Models for Drug Discovery  and Development—Current State-of-the-Art and Future Perspectives |  Pharmacological Reviews
Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives | Pharmacological Reviews

Ki-67 Antibody (14-5698-82)
Ki-67 Antibody (14-5698-82)

Nano in der Apotheke: Risiko, Perspektiven oder nur Mythos? Nano damals.  pharma4u-webinar mit freundlicher Unterstützung von - PDF Free Download
Nano in der Apotheke: Risiko, Perspektiven oder nur Mythos? Nano damals. pharma4u-webinar mit freundlicher Unterstützung von - PDF Free Download

Research on Bioactive Glass Nanospheres as Delivery
Research on Bioactive Glass Nanospheres as Delivery

WISSENSCHAFTLICHE AKTIVITÄTEN
WISSENSCHAFTLICHE AKTIVITÄTEN

Untitled
Untitled

Modularized Gold Nanocarriers for TAT‐Mediated Delivery of siRNA - Huang -  2017 - Small - Wiley Online Library
Modularized Gold Nanocarriers for TAT‐Mediated Delivery of siRNA - Huang - 2017 - Small - Wiley Online Library

Publikationsverzeichnis Klinik-Apotheke Publikationen (Originalarbeiten,  Übersichtsarbeiten) 2020 2019
Publikationsverzeichnis Klinik-Apotheke Publikationen (Originalarbeiten, Übersichtsarbeiten) 2020 2019

Materials for Improving Immune Cell Transfection - Kumar - 2021 - Advanced  Materials - Wiley Online Library
Materials for Improving Immune Cell Transfection - Kumar - 2021 - Advanced Materials - Wiley Online Library

Jahresbericht 2009
Jahresbericht 2009

Pharmaceutics | Free Full-Text | Safe and Effective Cynomolgus Monkey  GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2  Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for  Neurodegenerative Disorders | HTML
Pharmaceutics | Free Full-Text | Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders | HTML